Eskayef sets pharmaceutical export milestone

Eskayef Pharmaceuticals Ltd. has set a milestone by stepping into the arena of global supply of high-tech biological vial products. An agreement was signed between Eskayef Pharmaceuticals Ltd, Bangladesh and a leading multinational biotech company on Thursday in Dhaka on export of high-tech biological products, says a press release.
Under this agreement, Eskayef will export biological vial products to different parts of the world. Eskayef will supply millions of biological vials annually to the global supply chain. This export agreement is a milestone for Bangladesh's pharmaceutical sector as it signifies the biggest ever annual export contract signed by any pharmaceutical company in the country.
Ms. Simeen Rahman, Group CEO of Transcom Limited, and Managing Director and CEO of Eskayef Pharmaceuticals, stated, "Exporting biological vials is not just a milestone for Eskayef, I believe it is a great step taken to serve millions of patients".
"It is a proud moment for the country as this achievement marks the level of advancement of Bangladesh's pharmaceutical industry now that high-tech biological products are being made in Bangladesh for export", she added.
Major General Mohammad Yousuf, Director General, Directorate General of Drug Administration (DGDA), said, "We are exporting not only the generics but also the high-tech products and this is a milestone in the history of Bangladesh that a biological product, that is a high-tech product, will be exported from Bangladesh."
National Professor Dr. AK Azad Khan said, "The biological products that will be exported through this collaboration will surely be beneficial for the humankind."
Since 2012 Eskayef has been manufacturing biological products from its dedicated facility of the leading biotech company for Bangladesh's market. The facility is equipped with modern technology and machinery capable of producing world class biotech products while maintaining the highest level of GMP standards. To serve the supply requirement, Eskayef will go for further production capacity expansion.
The major global accreditations of Eskayef include US FDA, UK MHRA, EU GMP, Brazil ANVISA, Australia TGA and South Africa SAHPRA and with these approvals by the world's stringent pharmaceutical regulatory authorities, Eskayef is positioning itself to become a global pharma company by setting the highest standards of quality, safety and efficacy of its medicines.